NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹466 Cr | ₹428 Cr | ₹439 Cr | ₹363 Cr | ₹369 Cr |
What is the latest Total Current Liabilities ratio of NEULAND LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹466 Cr |
Mar2024 | ₹428 Cr |
Mar2023 | ₹439 Cr |
Mar2022 | ₹363 Cr |
Mar2021 | ₹369 Cr |
How is Total Current Liabilities of NEULAND LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹466 Cr | 8.89 | |
Mar2024 | ₹428 Cr | -2.57 | |
Mar2023 | ₹439 Cr | 20.87 | |
Mar2022 | ₹363 Cr | -1.45 | |
Mar2021 | ₹369 Cr | - |
Compare Total Current Liabilities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹16,416.0 Cr | -7.8% | 8.8% | 18.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,607.0 Cr | -5.9% | -2.8% | -5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹170,148.0 Cr | -3.7% | -6.9% | 30.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,471.0 Cr | -3.8% | 7.1% | 12% | Stock Analytics | |
CIPLA | ₹121,103.0 Cr | -3.9% | -0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,306.0 Cr | -6% | -7.3% | -12% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -7.8% |
8.8% |
18.1% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses